SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. Feuerstadt P, Louie TJ, Lashner B, Wang EEL, et al. N Engl J Med 2022;386:220-229.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Feuerstadt P, Louie TJ, Lashner B, Wang EEL, et al. SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med 2022;386:220-229.
PMID: 35045228